Loading...

APC anti-mouse TER-119/Erythroid Cells Antibody

Pricing & Availability
Clone
TER-119 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-76
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
TER-119_APC_122107
C57BL/6 bone marrow cells stained with TER-119 APC and anti-mouse CD45 FITC
  • TER-119_APC_122107
    C57BL/6 bone marrow cells stained with TER-119 APC and anti-mouse CD45 FITC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
116211 25 µg 36€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
116212 100 µg 111€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The TER-119 antigen is a 52 kD glycophorin A-associated protein, also known as Ly-76. TER-119 is an erythroid-specific antigen expressed on early proerythroblasts to mature erythrocytes, but not on erythroid colony-forming cells (BFU-E, blast-forming unit erythroid, or CFU-E, colony-forming unit erythroid).

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Day-14 fetal liver cells from a C57BL/6 mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1, complement-mediated cytotoxicity3, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References
  1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
  2. Vannucchi AM, et al. 2000. Blood 95:2559.
  3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
  4. Grisendi S, et al. 2005. Nature 437:147. (FC)
  5. Bourdeau A, et al. 2007. Blood 109:4220.
  6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
  7. Heuser M, et al. 2007. Blood 110:1639. (FC)
  8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed
Product Citations
  1. Yang D, et al. 2022. Cell. 185:1905. PubMed
  2. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  3. Kozuki S, et al. 2022. Genes Cells. 27:192. PubMed
  4. Yousefi M, et al. 2022. Cancer Res. 82:1589. PubMed
  5. Tátrai P, et al. 2022. EMBO J. 41:e108739. PubMed
  6. Cattaneo P, et al. 2022. Nat Commun. 13:7444. PubMed
  7. Wu Q, et al. 2023. Cell Rep. 42:112057. PubMed
  8. Leick MB, et al. 2022. Cancer Cell. 40:494. PubMed
  9. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  10. Koury D, et al. 2017. Int J Parasitol. 10.1016/j.ijpara.2017.05.009. PubMed
  11. Wang L, et al. 2018. Bone Res. 6:22. PubMed
  12. Ray S, et al. 2022. Elife. 11:. PubMed
  13. Awida Z, et al. 2022. Int J Mol Sci. 23:. PubMed
  14. Gómez-Salinero JM, et al. 2022. Nat Cardiovasc Res. 1:882. PubMed
  15. Peng YJ, et al. 2023. Development. 150:. PubMed
  16. Kawai H, et al. 2023. JBMR Plus. 7:e10722. PubMed
  17. Kalgudde Gopal S, et al. 2023. Nat Commun. 14:3020. PubMed
  18. Sucre JM, et al. 2023. JCI Insight. . PubMed
  19. Menolfi D, et al. 2023. Nat Commun. 14:3618. PubMed
  20. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  21. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  22. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  23. Ray S, et al. 2020. J Biol Chem. 295:7113. PubMed
  24. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
  25. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  26. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  27. Li C, et al. 2021. Mol Ther. 29:822. PubMed
  28. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
  29. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
  30. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
  31. Lutzmann M, et al. 2019. Cell Rep. 28:2851. PubMed
  32. Liu P, et al. 2020. Genome Res. 30:1655. PubMed
  33. Nishina T, et al. 2021. Nat Commun. 12:2281. PubMed
  34. Yeo S, et al. 2016. Cancer Res . 76: 3397 - 3410. PubMed
  35. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  36. Bilodeau M, et al. 2009. PLoS One. 4:e7500. PubMed
  37. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  38. Liu S, et al. 2021. Mol Ther. 29:1918. PubMed
  39. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
  40. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  41. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  42. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  43. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  44. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  45. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  46. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  47. Negretti NM, et al. 2021. Development. 148:. PubMed
  48. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
  49. Guihard S, et al. 2010. Blood. 115:3686. PubMed
  50. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  51. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  52. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
  53. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  54. Saleiro D, et al. 2022. Nat Commun. 13:1750. PubMed
  55. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
  56. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
  57. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  58. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  59. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
  60. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  61. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  62. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  63. Shin JJ, et al. 2020. Cell Rep. 32:108093. PubMed
  64. Long JT, et al. 2022. Elife. 11:. PubMed
  65. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  66. Li G, et al. 2020. J Clin Invest. 130:1233. PubMed
  67. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  68. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  69. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  70. Song J, et al. 2014. Exp Cell Res. 327:123. PubMed
  71. Wang H, et al. 2019. J Clin Invest. 129:598. PubMed
  72. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  73. Liu W, et al. 2022. J Clin Invest. 132: . PubMed
  74. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  75. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
  76. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  77. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  78. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
  79. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  80. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  81. Maeda K, et al. 2021. Pathogens. 10:. PubMed
  82. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  83. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  84. Cambridge E, et al. 2017. Exp Hematol. 45:64-68.e5. PubMed
  85. Markworth JF, et al. 2020. JCI Insight. 5:00. PubMed
  86. Wang H, et al. 2020. JCI Insight. 5:00. PubMed
  87. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
  88. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  89. Khoriaty R, et al. 2014. Mol Cell Biol. 34:3721. PubMed
  90. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  91. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  92. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  93. Yin Y, et al. 2016. J Biol Chem. 291: 6923 - 6935. PubMed
  94. Rowe R, et al. 2016. J Exp Med. 213: 1497 - 1512. PubMed
  95. Werner MT, et al. 2020. J Biol Chem. 295:1898. PubMed
  96. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  97. Schmidts A, et al. 2020. J Immunother Cancer. 8:. PubMed
  98. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  99. Lam J, et al. 2018. Nat Commun. 9:2418. PubMed
RRID
AB_313712 (BioLegend Cat. No. 116211)
AB_313712 (BioLegend Cat. No. 116212)

Antigen Details

Structure
Associated with glycophorin A, 52 kD
Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type
Erythrocytes
Biology Area
Immunology
Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID
104231 View all products for this Gene ID
UniProt
View information about TER-119 on UniProt.org

Other Formats

View All TER-119 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse TER-119/Erythroid Cells TER-119 FC
Biotin anti-mouse TER-119/Erythroid Cells TER-119 FC
FITC anti-mouse TER-119/Erythroid Cells TER-119 FC
PE anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine5 anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB
Alexa Fluor® 488 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 647 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 700 anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP/Cyanine5.5 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 421™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Pacific Blue™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 650™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 510™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 605™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells (Maxpar® Ready) TER-119 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 785™ anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-A0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
APC/Fire™ 750 anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-B0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
TotalSeq™-C0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
Ultra-LEAF™ Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB,CMCD
Spark Blue™ 550 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Fire™ 810 anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark NIR™ 685 anti-mouse TER-119/Erythroid Cells Antibody TER-119 FC
Brilliant Violet 711™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark Red™ 718 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark Blue™ 574 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Go To Top Version: 2    Revision Date: 12/04/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account